D-382-2014 Class III Terminated

Recalled by Teva Pharmaceuticals USA — Horsham, PA

FDA drug recall D-382-2014 was initiated by Teva Pharmaceuticals USA on Dec 4, 2013 and is designated Class III. Reason for recall: Defective Delivery System: There is a potential for some units in certain lots of Qnasl Nasal Aerosol 80 mcg metered spray to have clogged stem valves. The recall status is terminated (terminated Aug 27, 2014). Affected quantity: 379,463 inhalers.

Recall details

Product Type
Drugs
Report Date
Jan 1, 2014
Initiation Date
Dec 4, 2013
Termination Date
Aug 27, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
379,463 inhalers

Product description

Qnasl (beclomethasone dipropionate) Nasal Aerosol, 80 mcg per spray, 120 metered sprays, 8.7 g inhaler, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044; By: 3M Delivery Systems, Northridge, CA 91324, NDC 59310-210-12, UPC 3 59310 21012 9.

Reason for recall

Defective Delivery System: There is a potential for some units in certain lots of Qnasl Nasal Aerosol 80 mcg metered spray to have clogged stem valves.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: 120004, Exp 01/14; 120095, 120131, 120131 2, Exp 03/14; 120271, Exp 07/14; 120351, Exp 08/14

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-382-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-382-2014. Report a data issue: hello@regdatalab.com.